MKKGY
Price
$26.43
Change
+$0.61 (+2.36%)
Updated
Aug 15 closing price
Capitalization
56.5B
88 days until earnings call
ZTS
Price
$154.11
Change
+$1.05 (+0.69%)
Updated
Aug 15 closing price
Capitalization
68.3B
75 days until earnings call
Interact to see
Advertisement

MKKGY vs ZTS

Header iconMKKGY vs ZTS Comparison
Open Charts MKKGY vs ZTSBanner chart's image
Merck KGaA
Price$26.43
Change+$0.61 (+2.36%)
Volume$82.3K
Capitalization56.5B
ZOETIS
Price$154.11
Change+$1.05 (+0.69%)
Volume$3.71M
Capitalization68.3B
MKKGY vs ZTS Comparison Chart in %
Loading...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MKKGY vs. ZTS commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKKGY is a Hold and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (MKKGY: $26.43 vs. ZTS: $154.11)
Brand notoriety: MKKGY: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: MKKGY: 52% vs. ZTS: 112%
Market capitalization -- MKKGY: $56.5B vs. ZTS: $68.3B
MKKGY [@Pharmaceuticals: Generic] is valued at $56.5B. ZTS’s [@Pharmaceuticals: Generic] market capitalization is $68.3B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MKKGY’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • MKKGY’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, ZTS is a better buy in the long-term than MKKGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MKKGY’s TA Score shows that 5 TA indicator(s) are bullish while ZTS’s TA Score has 6 bullish TA indicator(s).

  • MKKGY’s TA Score: 5 bullish, 3 bearish.
  • ZTS’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than MKKGY.

Price Growth

MKKGY (@Pharmaceuticals: Generic) experienced а +4.10% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was +4.59% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Reported Earning Dates

MKKGY is expected to report earnings on Nov 13, 2025.

ZTS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($68.3B) has a higher market cap than MKKGY($56.5B). ZTS has higher P/E ratio than MKKGY: ZTS (26.52) vs MKKGY (17.12). ZTS YTD gains are higher at: -4.489 vs. MKKGY (-6.034). MKKGY has higher annual earnings (EBITDA): 6.04B vs. ZTS (3.91B). ZTS has less debt than MKKGY: ZTS (6.75B) vs MKKGY (8.7B). MKKGY has higher revenues than ZTS: MKKGY (21.3B) vs ZTS (9.29B).
MKKGYZTSMKKGY / ZTS
Capitalization56.5B68.3B83%
EBITDA6.04B3.91B155%
Gain YTD-6.034-4.489134%
P/E Ratio17.1226.5265%
Revenue21.3B9.29B229%
Total Cash1.62BN/A-
Total Debt8.7B6.75B129%
FUNDAMENTALS RATINGS
MKKGY vs ZTS: Fundamental Ratings
MKKGY
ZTS
OUTLOOK RATING
1..100
5013
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
35
Fair valued
PROFIT vs RISK RATING
1..100
9387
SMR RATING
1..100
6919
PRICE GROWTH RATING
1..100
6060
P/E GROWTH RATING
1..100
9183
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKKGY's Valuation (23) in the null industry is in the same range as ZTS (35) in the Pharmaceuticals Generic industry. This means that MKKGY’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's Profit vs Risk Rating (87) in the Pharmaceuticals Generic industry is in the same range as MKKGY (93) in the null industry. This means that ZTS’s stock grew similarly to MKKGY’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is somewhat better than the same rating for MKKGY (69) in the null industry. This means that ZTS’s stock grew somewhat faster than MKKGY’s over the last 12 months.

ZTS's Price Growth Rating (60) in the Pharmaceuticals Generic industry is in the same range as MKKGY (60) in the null industry. This means that ZTS’s stock grew similarly to MKKGY’s over the last 12 months.

ZTS's P/E Growth Rating (83) in the Pharmaceuticals Generic industry is in the same range as MKKGY (91) in the null industry. This means that ZTS’s stock grew similarly to MKKGY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MKKGYZTS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
53%
Momentum
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
55%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 24 days ago
61%
Bullish Trend 2 days ago
56%
Declines
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 17 days ago
56%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ETON17.040.34
+2.04%
Eton Pharmaceuticals
YHNA10.450.01
+0.10%
YHN Acquisition I Ltd
AVAV246.65-3.08
-1.23%
AeroVironment
LFST5.44-0.14
-2.51%
LifeStance Health Group
VERO2.32-0.13
-5.31%
Venus Concept

MKKGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKKGY
1D Price
Change %
MKKGY100%
+2.36%
MKGAF - MKKGY
49%
Loosely correlated
+1.94%
AMPH - MKKGY
25%
Poorly correlated
-1.26%
ZTS - MKKGY
25%
Poorly correlated
+0.69%
SUPN - MKKGY
25%
Poorly correlated
+1.23%
INDV - MKKGY
24%
Poorly correlated
+1.25%
More